Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 2, 2023
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
[ Tue, May 02nd 2023
] - WOPRAI
Mon, May 1, 2023
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
[ Mon, May 01st 2023
] - WOPRAI
John Ransom Upgraded (ALHC) to Buy and Held Target at $9 on, May 1st, 2023
John Ransom of Raymond James, Upgraded "Alignment Healthcare, Inc." (ALHC) to Buy and Held Target at $9 on, May 1st, 2023.
John has made no other calls on ALHC in the last 4 months.
There are 4 other peers that have a rating on ALHC. Out of the 4 peers that are also analyzing ALHC, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Lisa Gill of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $12 on, Thursday, February 23rd, 2023
These are the ratings of the 3 analyists that currently disagree with John
- Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $12 on, Wednesday, April 19th, 2023
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $12 on, Friday, March 3rd, 2023
- Gary Taylor of "TD Cowen" Maintained at Buy with Decreased Target to $10 on, Thursday, March 2nd, 2023
